Lawrence J. Green

Dermatology

9601 Blackwell Rd Ste 260
Rockville, MD 20850

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 85 publications

Roflumilast foam versus vehicle foam for seborrheic dermatitis (STRATUM clinical study): a plain language summary.

Roflumilast foam versus vehicle foam for seborrheic dermatitis (STRATUM clinical study): a plain language summary.

Journal: The Journal of dermatological treatment

Published: June 11, 2026

Post-marketing Safety Surveillance of Sofpironium Gel, 12.45%, A Novel Treatment for Primary Axillary Hyperhidrosis in Patients ≥9 Years.

Post-marketing Safety Surveillance of Sofpironium Gel, 12.45%, A Novel Treatment for Primary Axillary Hyperhidrosis in Patients ≥9 Years.

Journal: Journal of the American Academy of Dermatology

Published: April 27, 2026

Zasocitinib (TAK-279), a Highly Selective Oral TYK2 Inhibitor, Demonstrates Skin Clearance in Patients with Moderate-to-Severe Plaque Psoriasis: Post Hoc Analyses of a Randomized Phase IIb Trial.

Zasocitinib (TAK-279), a Highly Selective Oral TYK2 Inhibitor, Demonstrates Skin Clearance in Patients with Moderate-to-Severe Plaque Psoriasis: Post Hoc Analyses of a Randomized Phase IIb Trial.

Journal: Dermatology and therapy

Published: January 27, 2026

GW240925 and GW250207: Astrophysical Calibration of Gravitational Wave Detectors.

GW240925 and GW250207: Astrophysical Calibration of Gravitational Wave Detectors.

Journal: Physical review letters

Published: January 27, 2026

Black Hole Spectroscopy and Tests of General Relativity with GW250114.

Black Hole Spectroscopy and Tests of General Relativity with GW250114.

Journal: Physical review letters

Published: September 12, 2025

GW250114: Testing Hawking's Area Law and the Kerr Nature of Black Holes.

GW250114: Testing Hawking's Area Law and the Kerr Nature of Black Holes.

Journal: Physical review letters

Published: August 13, 2025

Resolving Hyperkeratotic Psoriasis: Mechanisms of Action and Additive Effects of Fixed-Combination Halobetasol Propionate and Tazarotene.

Resolving Hyperkeratotic Psoriasis: Mechanisms of Action and Additive Effects of Fixed-Combination Halobetasol Propionate and Tazarotene.

Journal: Journal of drugs in dermatology : JDD

Published: August 07, 2025

Efficacy and safety of ruxolitinib cream combined with narrow-band UVB phototherapy for treatment of vitiligo.

Efficacy and safety of ruxolitinib cream combined with narrow-band UVB phototherapy for treatment of vitiligo.

Journal: The Journal of investigative dermatology

Published: July 21, 2025

Brodalumab as a Second-Line Therapy in Psoriasis: Rapid Response and Unique Mechanism of Action After Biologic Failure.

Brodalumab as a Second-Line Therapy in Psoriasis: Rapid Response and Unique Mechanism of Action After Biologic Failure.

Journal: Dermatology and therapy

Published: July 02, 2025

Guselkumab for Moderate to Severe Psoriasis Across All Skin Tones: Cohort A of the VISIBLE Randomized Clinical Trial.

Guselkumab for Moderate to Severe Psoriasis Across All Skin Tones: Cohort A of the VISIBLE Randomized Clinical Trial.

Journal: JAMA dermatology

Published: June 25, 2025

Defining On-Treatment Remission in Plaque Psoriasis: A Consensus Statement From the National Psoriasis Foundation.

Defining On-Treatment Remission in Plaque Psoriasis: A Consensus Statement From the National Psoriasis Foundation.

Journal: JAMA dermatology

Published: June 18, 2025

Efficacy and Safety of Spironolactone in Acne Management.

Efficacy and Safety of Spironolactone in Acne Management.

Journal: Cutis

Published: May 20, 2025

Showing 1-12 of 85

Last Updated: 09/26/2026